PTC Therapeutics | Passifs Courants



Current Liabilities Changement Date
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 20.48B 2.53B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Cytokinetics USD 131.06M 28.66M 2025-06
Daiichi Sankyo JPY 799.97B 45.94B 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
Incyte USD 1.28B 608.18M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
Novartis USD 31.71B 95M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
PTC Therapeutics USD 627.81M 32.42M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
TG Therapeutics USD 171.89M 11.68M 2025-06
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06
Xencor USD 96.08M 7.65M 2025-06


PTC Therapeutics Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.